President Trump’s nominee for Attorney General, William Barr, stated in his confirmation hearing that he would not go after cannabis companies that were compliant with state laws. In a recent letter in response to written questions from various senators, Barr has put that statement in writing.
President Trump’s nominee for Attorney General, William Barr, stated in his confirmation hearing that he would not go after cannabis companies that were compliant with state laws. In a recent letter in response to written questions from various senators (1,2), Barr has put that statement in writing.
"As discussed at my hearing, I do not intend to go after parties who have complied with state law in reliance on the Cole Memorandum," he wrote. The Cole Memorandum, which generally directed federal prosecutors not to interfere with state cannabis laws, was an Obama-era cannabis enforcement guidance that former Attorney General Jeff Sessions rescinded last year. According to an article by Forbes.com (2), Barr isn't committing to formally replacing the Cole Memorandum with new guidance reiterating the approach.
"I have not closely considered or determined whether further administrative guidance would be appropriate following the Cole Memorandum and the January 2018 memorandum from Attorney General Sessions, or what such guidance might look like," he wrote in response to a question from Senator Cory Booker (D-NJ). "If confirmed, I will give the matter careful consideration."
Barr also said that he supports expanding the number of institutions that are allowed to grow cannabis for scientific research. "I support the expansion of marijuana manufacturers for scientific research consistent with law," he wrote in response to a question from Senator Charles Grassley (R-IA). "If confirmed, I will review the matter and take appropriate steps."
Barr made additional comments about looking into the medical and scientific studies surrounding cannabidiol (CBD). For more information, please read the article on Forbes.com.
Best of the Week: July 4 – July 10, 2025
July 11th 2025Here, we bring you our top five recent articles covering revoking medical cannabis cards in Florida, testing and sampling initiative in Missouri, our mid-year regulations roundup, depenalization ordinance stopped in Texas, and accuracy in THC labeling in flower versus concentrates.
Best of the Week: June 27 – July 03, 2025
July 4th 2025Here, we bring you our top five recent articles covering cannabis on state-tribal cannabis regulations in Montana, our podcast discussion on cannabis cultivation, our blog on compliance with federal regulations, public commentary on new standards, and hemp packaging enforcement in Florida.
Best of the Week: June 13 – June 19, 2025
June 20th 2025Here, we bring you our top five recent articles covering medical cannabis in Hawaii, a new dispensary in Connecticut, pesticide testing in California, a cease-and-desist letter to a dispensary on Long Island, and a global survey on cannabis for endometriosis.
Best of the Week: June 6 – June 12, 2025
June 13th 2025Here, we bring you our top five recent articles covering safety regulations in North Carolina, licenses in Minnesota, the FDA’s FY2026 Agriculture appropriations bill, cannabis taxes in California, and antifungal properties of CBD and CBDV.